CHRISTIE AMBRIZ: Open Payments
NPI 1770791279 · RAYMONDVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 41 payments from 11 companies in 2025. Trend: 2023 $521 · 2024 $810 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $185 |
| Novo Nordisk Inc | 4 | $67 |
| ANI Pharmaceuticals, Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $24 |
| Lilly USA, LLC | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Kerendia, OTEZLA, Ozempic, PURIFIED CORTROPHIN GEL, REPATHA, Cologuard Collection Kit, GEMTESA, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
